1990
DOI: 10.1016/0031-9384(90)90300-s
|View full text |Cite
|
Sign up to set email alerts
|

Are antibiotic effects on sleep behavior in the rat due to modulation of gut bacteria?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

1996
1996
2020
2020

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(18 citation statements)
references
References 12 publications
0
18
0
Order By: Relevance
“…It is in fact derived from the bacterial cell wall and thus released by gut bacteria (Collins & Bercik, 2009) and it provides yet another example of how bacterial products can influence brain activity and function. Rats given a strict antibiotic regimen exhibited greatly reduced slow-wave sleep and increased sleep onset latency (Brown, Price, King, & Husband, 1990). …”
Section: Biomarkers Of Interestmentioning
confidence: 99%
“…It is in fact derived from the bacterial cell wall and thus released by gut bacteria (Collins & Bercik, 2009) and it provides yet another example of how bacterial products can influence brain activity and function. Rats given a strict antibiotic regimen exhibited greatly reduced slow-wave sleep and increased sleep onset latency (Brown, Price, King, & Husband, 1990). …”
Section: Biomarkers Of Interestmentioning
confidence: 99%
“…Studies suggest that GI bacteria are an important source of Factor-S because normal sleep patterns were disrupted after perturbation of the microbiota with oral antibiotics. 76,77 Commensal bacteria also produce precursors of benzodiazepine receptor ligands that could contribute to encephalopathy in a rat model of liver failure. 46 Cognitive function improved in patients with minimal hepatic encephalopathy given Bifidobacterium longum with fructo-oligosaccharide for 9 weeks.…”
Section: Ability Of Microbiota To Influence the Brain And Behaviormentioning
confidence: 99%
“…In the present study, we highlight a previously unrecognized risk factor, namely antibiotic-induced dysbiosis, and call attention to the profound implications for clinical practice given that more than 270 million antibiotic prescriptions are issued in the US each year (Suda et al, 2014). There is now direct experimental evidence in mice (this study), rats (Brown et al, 1990), and humans (Nonaka et al, 1983) indicating that antibiotics may be insomnogenic. Additionally, Perlis et al (2006) used the Physicians' Desk Reference to document the clinical occurrence of insomnia with respect to seven classes of antibiotics and found that five of the classes were associated with insomnia as a side effect.…”
Section: Discussionmentioning
confidence: 75%